News|Articles|April 5, 2004

New Product Newswire

New Product Newswire for April 5, 2004

Newsletter

Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.

Subscribe Now!

Related Content

Woman in pink sweater making heart with hands | Image credit: WHstudio Leushin N - stock.adobe.com

Women’s Health: Top Stories of 2025

ByLaura Joszt, MA

December 23rd 2025

HRT, Hormonal Replacement Therapy, Women's Health, FDA Black Box Warning

Scripted for Her: HRT Black Box Removal

ByBrian Nowosielski,Natalie DiPietro Mager, PharmD, PhD,Karen Kier, PhD, RPh, BCPS, BCACP

December 17th 2025

FDA Expands Approval of Flibanserin for Postmenopausal Women’s Sexual Health

ByAshley Gallagher

December 15th 2025

FDA Approves Etripamil as First At-Home Option for Paroxysmal Supraventricular Tachycardia

ByAshley Gallagher

December 15th 2025

FDA, COVID-19 vaccine, Center for Biologics Evaluation and Research

FDA Enforces Stricter Vaccine Development, Linking COVID Vaccine to Pediatric Deaths

ByBrian Nowosielski

December 1st 2025

New Product Newswire

Newsletter

Related Content

Women’s Health: Top Stories of 2025

Scripted for Her: HRT Black Box Removal

FDA Expands Approval of Flibanserin for Postmenopausal Women’s Sexual Health

FDA Approves Etripamil as First At-Home Option for Paroxysmal Supraventricular Tachycardia

FDA Enforces Stricter Vaccine Development, Linking COVID Vaccine to Pediatric Deaths

Trending on Drug Topics

Top 5 Stories in Pharmacy From 2025

COVID-19: Most-Read Stories of 2025

Obesity Management: Most-Read Stories of 2025

Protecting Patient Privacy Safeguards Pharmacists’ Professional Reputation

Top 5 Videos of 2025 Focus Primarily on PBM Reform